Xiong-wei Zhu
#136,787
Most Influential Person Now
Xiong-wei Zhu's AcademicInfluence.com Rankings
Xiong-wei Zhubiology Degrees
Biology
#9426
World Rank
#12632
Historical Rank
Cell Biology
#402
World Rank
#412
Historical Rank
Molecular Biology
#1290
World Rank
#1317
Historical Rank
Neuroscience
#1378
World Rank
#1425
Historical Rank
Download Badge
Biology
Xiong-wei Zhu's Degrees
- PhD Cell Biology University of California, San Diego
- Bachelors Biology Peking University
Similar Degrees You Can Earn
Why Is Xiong-wei Zhu Influential?
(Suggest an Edit or Addition)Xiong-wei Zhu's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes (2008) (2360)
- Impaired Balance of Mitochondrial Fission and Fusion in Alzheimer's Disease (2009) (981)
- Oxidative stress and mitochondrial dysfunction in Alzheimer's disease. (2014) (940)
- Amyloid-β overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins (2008) (742)
- Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology. (2010) (610)
- Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease. (2013) (568)
- Involvement of Oxidative Stress in Alzheimer Disease (2006) (556)
- Oxidative stress in Alzheimer disease: A possibility for prevention (2010) (446)
- Alzheimer's disease: the two-hit hypothesis (2004) (417)
- Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer’s disease (2012) (416)
- Activation and redistribution of c‐Jun N‐terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease (2001) (409)
- Oxidative stress signalling in Alzheimer's disease (2004) (393)
- LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1. (2012) (380)
- Mitochondria dysfunction in the pathogenesis of Alzheimer’s disease: recent advances (2020) (361)
- Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment. (2010) (350)
- The Role of Mitogen-Activated Protein Kinase Pathways in Alzheimer’s Disease (2002) (345)
- Activation of p38 Kinase Links Tau Phosphorylation, Oxidative Stress, and Cell Cycle‐Related Events in Alzheimer Disease (2000) (345)
- Redox-active iron mediates amyloid-β toxicity (2001) (340)
- Dynamin-like protein 1 reduction underlies mitochondrial morphology and distribution abnormalities in fibroblasts from sporadic Alzheimer's disease patients. (2008) (303)
- Is oxidative damage the fundamental pathogenic mechanism of Alzheimer's and other neurodegenerative diseases? (2002) (302)
- Differential activation of neuronal ERK, JNK/SAPK and p38 in Alzheimer disease: the ‘two hit’ hypothesis (2001) (302)
- Oxidative Stress and Neurodegeneration (2005) (300)
- Microtubule reduction in Alzheimer's disease and aging is independent of tau filament formation. (2003) (290)
- Modulation of Hippocampal Plasticity and Cognitive Behavior by Short-term Blueberry Supplementation in Aged Rats (2004) (283)
- Oxidative stress activates a positive feedback between the γ‐ and β‐secretase cleavages of the β‐amyloid precursor protein (2007) (283)
- Alzheimer disease, the two-hit hypothesis: an update. (2007) (274)
- Ribosomal RNA in Alzheimer Disease Is Oxidized by Bound Redox-active Iron* (2005) (270)
- Role of metal dyshomeostasis in Alzheimer's disease. (2011) (265)
- The role of abnormal mitochondrial dynamics in the pathogenesis of Alzheimer’s disease (2009) (257)
- Mitochondria: a therapeutic target in neurodegeneration. (2010) (253)
- Abnormal mitochondrial dynamics and neurodegenerative diseases. (2010) (252)
- Oxidative stress in diabetes and Alzheimer's disease. (2009) (243)
- Parkinson’s disease-associated mutant VPS35 causes mitochondrial dysfunction by recycling DLP1 complexes (2015) (243)
- Tau phosphorylation in Alzheimer's disease: pathogen or protector? (2005) (232)
- Leptin reduces pathology and improves memory in a transgenic mouse model of Alzheimer's disease. (2010) (209)
- In Alzheimer's Disease, Heme Oxygenase Is Coincident with Alz50, an Epitope of τ Induced by 4‐Hydroxy‐2‐Nonenal Modification (2000) (200)
- Insulin-resistant brain state: The culprit in sporadic Alzheimer's disease? (2011) (198)
- Abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease. (2012) (195)
- Parkinson’s disease‐associated DJ‐1 mutations impair mitochondrial dynamics and cause mitochondrial dysfunction (2012) (191)
- Oxidative stress activates a positive feedback between the gamma- and beta-secretase cleavages of the beta-amyloid precursor protein. (2008) (187)
- The Roc domain of leucine‐rich repeat kinase 2 is sufficient for interaction with microtubules (2008) (184)
- Iron: The Redox-active Center of Oxidative Stress in Alzheimer Disease (2007) (184)
- Challenging the Amyloid Cascade Hypothesis: Senile Plaques and Amyloid‐β as Protective Adaptations to Alzheimer Disease (2004) (183)
- Vascular oxidative stress in Alzheimer disease (2007) (180)
- Tau – an inhibitor of deacetylase HDAC6 function (2009) (179)
- The sirtuin pathway in ageing and Alzheimer disease: mechanistic and therapeutic considerations (2011) (175)
- Mitochondrial abnormalities and oxidative imbalance in Alzheimer disease. (2006) (173)
- Lipoic acid and N-acetyl cysteine decrease mitochondrial-related oxidative stress in Alzheimer disease patient fibroblasts. (2007) (168)
- Alzheimer Disease Pathology As a Host Response (2008) (168)
- Ectopic localization of phosphorylated histone H3 in Alzheimer's disease: a mitotic catastrophe? (2003) (158)
- Oxidative Damage to RNA in Aging and Neurodegenerative Disorders (2012) (157)
- Abortive apoptosis in Alzheimer's disease (2001) (156)
- Insulin is a two-edged knife on the brain. (2009) (154)
- Alzheimer disease and the role of free radicals in the pathogenesis of the disease. (2008) (154)
- Antioxidant therapy in Alzheimer's disease: theory and practice. (2008) (149)
- Activation of MKK6, an upstream activator of p38, in Alzheimer's disease (2001) (145)
- Increased Autophagic Degradation of Mitochondria in Alzheimer Disease (2007) (142)
- Amyloid-β in Alzheimer Disease: The Null versus the Alternate Hypotheses (2007) (142)
- Oxidative imbalance in alzheimer’s disease (2007) (140)
- Chronic oxidative stress causes increased tau phosphorylation in M17 neuroblastoma cells (2010) (140)
- A synergistic dysfunction of mitochondrial fission/fusion dynamics and mitophagy in Alzheimer's disease. (2010) (140)
- Nanoparticle and other metal chelation therapeutics in Alzheimer disease. (2005) (139)
- Mitochondrial DNA oxidative damage and repair in aging and Alzheimer's disease. (2013) (138)
- Cell cycle re-entry mediated neurodegeneration and its treatment role in the pathogenesis of Alzheimer's disease (2009) (136)
- Reexamining Alzheimer's disease: evidence for a protective role for amyloid-beta protein precursor and amyloid-beta. (2009) (133)
- Evidence of DNA damage in Alzheimer disease: phosphorylation of histone H2AX in astrocytes (2008) (132)
- Oxidative stress: the old enemy in Alzheimer's disease pathophysiology. (2005) (131)
- NLRP3 Inflammasome Inhibitor Ameliorates Amyloid Pathology in a Mouse Model of Alzheimer’s Disease (2018) (130)
- Leptin reduces Alzheimer's disease-related tau phosphorylation in neuronal cells. (2008) (128)
- Neuropathology of Alzheimer disease: pathognomonic but not pathogenic (2006) (128)
- Leptin: a novel therapeutic strategy for Alzheimer's disease. (2009) (124)
- Alzheimer-specific epitopes of tau represent lipid peroxidation-induced conformations. (2005) (124)
- Phosphorylation of Tau Protein as the Link between Oxidative Stress, Mitochondrial Dysfunction, and Connectivity Failure: Implications for Alzheimer's Disease (2013) (123)
- Oxidative Damage to RNA in Neurodegenerative Diseases (2006) (123)
- Absence of cellular stress in brain after hypoxia induced by arousal from hibernation in Arctic ground squirrels. (2005) (121)
- LRRK2-mediated neurodegeneration and dysfunction of dopaminergic neurons in a Caenorhabditis elegans model of Parkinson's disease (2010) (120)
- Alzheimer's disease: diverse aspects of mitochondrial malfunctioning. (2010) (118)
- Antioxidant approaches for the treatment of Alzheimer’s disease (2010) (117)
- Cyclin' toward dementia (2000) (117)
- Mitochondrial failures in Alzheimer's disease (2004) (117)
- Amyloid-β-Derived Diffusible Ligands Cause Impaired Axonal Transport of Mitochondria in Neurons (2010) (115)
- Cellular prion protein is essential for oligomeric amyloid-β-induced neuronal cell death. (2012) (112)
- DLP1‐dependent mitochondrial fragmentation mediates 1‐methyl‐4‐phenylpyridinium toxicity in neurons: implications for Parkinson’s disease (2011) (111)
- All-trans retinoic acid as a novel therapeutic strategy for Alzheimer’s disease (2009) (111)
- Leptin inhibits glycogen synthase kinase-3β to prevent tau phosphorylation in neuronal cells (2009) (109)
- Skin α-Synuclein Aggregation Seeding Activity as a Novel Biomarker for Parkinson Disease (2020) (107)
- DJ-1 regulates the integrity and function of ER-mitochondria association through interaction with IP3R3-Grp75-VDAC1 (2019) (106)
- Dysregulation of leptin signaling in Alzheimer disease: evidence for neuronal leptin resistance (2014) (106)
- High-resolution analytical imaging and electron holography of magnetite particles in amyloid cores of Alzheimer’s disease (2016) (105)
- The Earliest Stage of Cognitive Impairment in Transition From Normal Aging to Alzheimer Disease Is Marked by Prominent RNA Oxidation in Vulnerable Neurons (2012) (104)
- Inhibition of mitochondrial fragmentation protects against Alzheimer’s disease in rodent model (2017) (103)
- Alzheimer disease: evidence for a central pathogenic role of iron-mediated reactive oxygen species. (2004) (100)
- Signal transduction cascades associated with oxidative stress in Alzheimer's disease. (2007) (98)
- Amyloid beta: the alternate hypothesis. (2006) (98)
- Activation of oncogenic pathways in degenerating neurons in Alzheimer disease (2000) (97)
- eIF2α Phosphorylation Tips the Balance to Apoptosis during Osmotic Stress* (2010) (96)
- Insights into amyloid-β-induced mitochondrial dysfunction in Alzheimer disease (2007) (93)
- Increased p27, an essential component of cell cycle control, in Alzheimer's disease (2003) (93)
- The cell cycle in Alzheimer disease: A unique target for neuropharmacology (2005) (93)
- Indoleamine 2,3-dioxygenase and 3-hydroxykynurenine modifications are found in the neuropathology of Alzheimer's disease (2010) (93)
- Oxidative Stress and its Implications for Future Treatments and Management of Alzheimer Disease (2010) (92)
- Contribution of redox-active iron and copper to oxidative damage in Alzheimer disease (2004) (91)
- The neuronal expression of MYC causes a neurodegenerative phenotype in a novel transgenic mouse. (2009) (90)
- Neuronal failure in Alzheimer’s disease: a view through the oxidative stress looking-glass (2014) (89)
- Apoptosis in Alzheimer disease: a mathematical improbability. (2006) (85)
- Pathological implications of cell cycle re-entry in Alzheimer disease (2010) (82)
- Amyloid-β42 Interacts Mainly with Insoluble Prion Protein in the Alzheimer Brain* (2011) (81)
- Mitochondrial biology in Alzheimer’s disease pathogenesis (2010) (81)
- Intraneuronal amyloid β accumulation and oxidative damage to nucleic acids in Alzheimer disease (2010) (81)
- c‐Jun phosphorylation in Alzheimer disease (2007) (80)
- Activation of the extracellular signal‐regulated kinase pathway contributes to the behavioral deficit of fragile x‐syndrome (2012) (79)
- Endoplasmic reticulum-mitochondria tethering in neurodegenerative diseases (2017) (79)
- Abnormal Mitochondrial Dynamics—A Novel Therapeutic Target for Alzheimer's Disease? (2010) (78)
- Physiological regulation of tau phosphorylation during hibernation (2008) (77)
- Kinase inhibitors arrest neurodegeneration in cell and C. elegans models of LRRK2 toxicity. (2013) (76)
- The role of iron as a mediator of oxidative stress in Alzheimer disease (2012) (75)
- Alzheimer's disease: cerebrovascular dysfunction, oxidative stress, and advanced clinical therapies. (2008) (75)
- Posttranslational modifications of α-tubulin in alzheimer disease (2015) (74)
- Cell cycle deregulation in the neurons of Alzheimer's disease. (2011) (74)
- Biomarkers in Alzheimer's disease: past, present and future. (2010) (73)
- Comparative biology and pathology of oxidative stress in Alzheimer and other neurodegenerative diseases: beyond damage and response. (2002) (71)
- LRRK2 protein is a component of lewy bodies (2006) (71)
- Amyloid-β, tau alterations and mitochondrial dysfunction in Alzheimer disease: the chickens or the eggs? (2002) (71)
- Amyloid-beta in Alzheimer disease: the null versus the alternate hypotheses. (2007) (69)
- Mitochondrial Dynamics in Alzheimer’s Disease (2010) (69)
- Individual Case Analysis of Postmortem Interval Time on Brain Tissue Preservation (2016) (69)
- Role of mitochondrial-mediated signaling pathways in Alzheimer disease and hypoxia (2009) (68)
- Prevention and treatment of Alzheimer disease and aging: antioxidants. (2007) (67)
- Oxidative stress and neuronal adaptation in Alzheimer disease: the role of SAPK pathways. (2003) (67)
- Trichosanthin induced apoptosis in HL-60 cells via mitochondrial and endoplasmic reticulum stress signaling pathways. (2007) (66)
- Causes versus effects: the increasing complexities of Alzheimer’s disease pathogenesis (2010) (66)
- Neurofilamentopathy in Neurodegenerative Diseases (2011) (65)
- Mitochondrial importance in Alzheimer's, Huntington's and Parkinson's diseases. (2012) (65)
- Neuronal CDK7 in hippocampus is related to aging and Alzheimer disease (2000) (64)
- Elevated expression of a regulator of the G2/M phase of the cell cycle, neuronal CIP‐1‐associated regulator of cyclin B, in Alzheimer's disease (2004) (62)
- Expression of CD74 is increased in neurofibrillary tangles in Alzheimer's disease (2008) (62)
- Ectopic expression of phospho‐Smad2 in Alzheimer's disease: Uncoupling of the transforming growth factor‐β pathway? (2006) (62)
- MicroRNA-26a/Death-Associated Protein Kinase 1 Signaling Induces Synucleinopathy and Dopaminergic Neuron Degeneration in Parkinson’s Disease (2019) (62)
- The Autistic Phenotype Exhibits a Remarkably Localized Modification of Brain Protein by Products of Free Radical-Induced Lipid Oxidation (2008) (62)
- Mfn2 ablation causes an oxidative stress response and eventual neuronal death in the hippocampus and cortex (2018) (61)
- JKK1, an upstream activator of JNK/SAPK, is activated in Alzheimer's disease (2003) (61)
- Early Induction of Oxidative Stress in Mouse Model of Alzheimer Disease with Reduced Mitochondrial Superoxide Dismutase Activity (2012) (61)
- Down‐regulation of serum gonadotropins is as effective as estrogen replacement at improving menopause‐associated cognitive deficits (2010) (61)
- Increased isoprostane and prostaglandin are prominent in neurons in Alzheimer disease (2007) (60)
- LRRK2 in Parkinson's disease and dementia with Lewy bodies (2006) (60)
- BRCA1 May Modulate Neuronal Cell Cycle Re-Entry in Alzheimer Disease (2007) (59)
- Bivalent ligand containing curcumin and cholesterol as fluorescence probe for Aβ plaques in Alzheimer's disease. (2012) (59)
- Distribution, levels, and activation of MEK1 in Alzheimer's disease (2003) (58)
- Nuclear and mitochondrial DNA oxidation in Alzheimer's disease (2012) (58)
- Neuroprotective effect of cocoa flavonids on in vitro oxidative stress (2009) (57)
- Detection and localization of markers of oxidative stress by in situ methods: application in the study of Alzheimer disease. (2010) (57)
- Aberrant expression of metabotropic glutamate receptor 2 in the vulnerable neurons of Alzheimer’s disease (2004) (56)
- Mitochondrial Preconditioning: A Potential Neuroprotective Strategy (2010) (55)
- Signaling effect of amyloid-β42 on the processing of AβPP (2010) (55)
- The role of metabotropic glutamate receptors in Alzheimer's disease. (2004) (54)
- Amyloid Beta and Tau Proteins as Therapeutic Targets for Alzheimer's Disease Treatment: Rethinking the Current Strategy (2012) (54)
- New Perspectives on Alzheimer's Disease and Nutrition. (2015) (53)
- Perspectives on the Amyloid-β Cascade Hypothesis (2004) (53)
- Amyloid‐β in Alzheimer's disease: the horse or the cart? Pathogenic or protective? (2005) (53)
- Neuronal polo-like kinase in Alzheimer disease indicates cell cycle changes (2000) (52)
- Miro1 deficiency in amyotrophic lateral sclerosis (2015) (51)
- Apoptotic promoters and inhibitors in Alzheimer's disease: Who wins out? (2003) (51)
- Antimicrobial peptide β-defensin-1 expression is upregulated in Alzheimer’s brain (2013) (51)
- Mutant Presenilin 1 Increases the Expression and Activity of BACE1* (2009) (50)
- Neuroprotective properties of Bcl‐w in Alzheimer disease (2004) (49)
- Antigen–antibody dissociation in Alzheimer disease: a novel approach to diagnosis (2008) (49)
- A Novel Origin for Granulovacuolar Degeneration in Aging and Alzheimer’s Disease: Parallels to Stress Granules (2011) (48)
- The suppression of ghrelin signaling mitigates age-associated thermogenic impairment (2014) (48)
- Sources and mechanisms of cytoplasmic oxidative damage in Alzheimer's disease. (2004) (47)
- Aberrant localization of importin α1 in hippocampal neurons in Alzheimer disease (2006) (47)
- Down‐regulation of serum gonadotropins but not estrogen replacement improves cognition in aged‐ovariectomized 3xTg AD female mice (2014) (47)
- Mitochondria: the missing link between preconditioning and neuroprotection. (2010) (47)
- Curcumin/melatonin hybrid 5-(4-hydroxy-phenyl)-3-oxo-pentanoic acid [2-(5-methoxy-1H-indol-3-yl)-ethyl]-amide ameliorates AD-like pathology in the APP/PS1 mouse model. (2015) (46)
- Mitochondrial dynamic abnormalities in amyotrophic lateral sclerosis (2015) (46)
- Molecular Pathogenesis of Alzheimer’s Disease: Reductionist versus Expansionist Approaches (2009) (45)
- Compensatory responses induced by oxidative stress in Alzheimer disease. (2006) (45)
- Therapeutic opportunities in Alzheimer disease: one for all or all for one? (2005) (44)
- The p38 pathway is activated in Pick disease and progressive supranuclear palsy: a mechanistic link between mitogenic pathways, oxidative stress, and tau (2002) (44)
- Consequences of RNA oxidation on protein synthesis rate and fidelity: implications for the pathophysiology of neuropsychiatric disorders. (2017) (43)
- Retinoblastoma protein phosphorylation at multiple sites is associated with neurofibrillary pathology in Alzheimer disease. (2008) (43)
- Novel therapeutics for Alzheimer's disease: an update. (2010) (42)
- Therapeutic options in Alzheimer’s disease (2006) (42)
- Alzheimer's disease and the cell cycle. (2004) (42)
- Chronological primacy of oxidative stress in Alzheimer disease (2005) (42)
- METTL3-dependent RNA m6A dysregulation contributes to neurodegeneration in Alzheimer’s disease through aberrant cell cycle events (2021) (41)
- Insights into amyloid-beta-induced mitochondrial dysfunction in Alzheimer disease. (2007) (41)
- Cell Cycle Re-Entry and Mitochondrial Defects in Myc-Mediated Hypertrophic Cardiomyopathy and Heart Failure (2009) (40)
- Activation of Akt by lithium: Pro-survival pathways in aging (2009) (40)
- Estrogen receptor-α is localized to neurofibrillary tangles in Alzheimer’s disease (2016) (40)
- P38 Activation Mediates Amyloid-β Cytotoxicity (2005) (39)
- Heme catabolism and heme oxygenase in neurodegenerative disease. (2004) (39)
- Streamlined alpha-synuclein RT-QuIC assay for various biospecimens in Parkinson’s disease and dementia with Lewy bodies (2021) (39)
- Neuropathology and treatment of Alzheimer disease: did we lose the forest for the trees? (2007) (39)
- Mfn2 protects dopaminergic neurons exposed to paraquat both in vitro and in vivo: Implications for idiopathic Parkinson's disease. (2017) (38)
- Getting the iron out: phlebotomy for Alzheimer's disease? (2009) (37)
- Steroidogenic Acute Regulatory Protein (StAR): Evidence of Gonadotropin-Induced Steroidogenesis in Alzheimer Disease (2006) (37)
- Ectopic localization of FOXO3a protein in Lewy bodies in Lewy body dementia and Parkinson's disease (2009) (37)
- Mfn2 Ablation in the Adult Mouse Hippocampus and Cortex Causes Neuronal Death (2020) (36)
- Insulin signaling, diabetes mellitus and risk of Alzheimer disease. (2005) (36)
- Differential Regulation of Glutamate Receptors in Alzheimer’s Disease (2002) (36)
- Emerging evidence for the neuroprotective role of α-synuclein (2006) (35)
- MAPKs are differentially modulated in arctic ground squirrels during hibernation (2005) (35)
- The mitochondrial dynamics of Alzheimer's disease and Parkinson's disease offer important opportunities for therapeutic intervention. (2011) (34)
- Book Review: Is Alzheimer’s Disease a Mitochondrial Disorder? (2002) (34)
- The Cell Cycle Regulator Phosphorylated Retinoblastoma Protein Is Associated With Tau Pathology in Several Tauopathies (2011) (34)
- Glutaredoxin deficiency exacerbates neurodegeneration in C. elegans models of Parkinson's disease. (2015) (34)
- The effect of mGluR2 activation on signal transduction pathways and neuronal cell survival (2009) (34)
- Leucine-Rich Repeat Kinase 2 Colocalizes with α-Synuclein in Parkinson’s Disease, but Not Tau-Containing Deposits in Tauopathies (2008) (34)
- Upregulation of Glutaredoxin-1 Activates Microglia and Promotes Neurodegeneration: Implications for Parkinson's Disease. (2016) (34)
- Beyond estrogen: targeting gonadotropin hormones in the treatment of Alzheimer's disease. (2004) (33)
- Oxidative damage and Alzheimer's disease: are antioxidant therapies useful? (2005) (33)
- Autophagy in Alzheimer’s disease (2010) (33)
- Parkinson's disease-associated pathogenic VPS35 mutation causes complex I deficits. (2017) (33)
- Mitogen‐ and stress‐activated protein kinase 1: Convergence of the ERK and p38 pathways in Alzheimer's disease (2005) (32)
- CXCL12 is involved in α-synuclein-triggered neuroinflammation of Parkinson’s disease (2019) (32)
- Frontiers in Alzheimer’s disease therapeutics (2011) (32)
- A conserved retromer sorting motif is essential for mitochondrial DLP1 recycling by VPS35 in Parkinson’s disease model (2016) (31)
- Neurons in Alzheimer disease emerge from senescence (2001) (31)
- Sequential formation of different layers of dystrophic neurites in Alzheimer’s brains (2019) (31)
- Hydroxynonenal-generated crosslinking fluorophore accumulation in Alzheimer disease reveals a dichotomy of protein turnover. (2012) (31)
- Regulation of DJ-1 by Glutaredoxin 1 in Vivo: Implications for Parkinson's Disease. (2016) (30)
- Biogenic metallic elements in the human brain? (2021) (30)
- Nanoparticle delivery of transition-metal chelators to the brain: Oxidative stress will never see it coming! (2012) (29)
- Distribution, levels and phosphorylation of Raf‐1 in Alzheimer's disease (2006) (29)
- PKC inhibition is involved in trichosanthin-induced apoptosis in human chronic myeloid leukemia cell line K562. (2007) (28)
- Neuroprotective effect of cocoa flavonoids on in vitro oxidative stress (2009) (28)
- Alzheimer's disease and oxidative stress: The old problem remains unsolved (2005) (26)
- Amyloid-beta in Alzheimer's disease: the horse or the cart? Pathogenic or protective? (2005) (26)
- Luteinizing hormone downregulation but not estrogen replacement improves ovariectomy-associated cognition and spine density loss independently of treatment onset timing (2016) (26)
- Microbial origin of glutamate, hibernation and tissue trauma: an in vivo microdialysis study (2002) (26)
- The neuroprotective effect of human uncoupling protein 2 (hUCP2) requires cAMP-dependent protein kinase in a toxin model of Parkinson's disease (2014) (25)
- Amyloid-β metabolite sensing: biochemical linking of glycation modification and misfolding. (2012) (25)
- Mitochondrial abnormalities and oxidative imbalance in neurodegenerative disease. (2002) (25)
- Apolipoprotein E4 Prevents Growth of Malaria at the Intraerythrocyte Stage: Implications For Diff erences in Racial Susceptibility to Alzheimer’s Disease (2013) (24)
- P38 activation mediates amyloid-beta cytotoxicity. (2005) (23)
- The key role of oxidative stress in alzheimer's disease (2007) (22)
- Will Preventing Protein Aggregates Live Up to Its Promise as Prophylaxis Against Neurodegenerative Diseases? (2003) (22)
- Probing and trapping a sensitive conformation: amyloid-β fibrils, oligomers, and dimers. (2012) (22)
- Accumulation of intraneuronal amyloid-β is common in normal brain. (2014) (21)
- Tipping the apoptotic balance in Alzheimer's disease (2007) (21)
- Ionizing radiation causes increased tau phosphorylation in primary neurons (2014) (21)
- The (un)balance between metabolic and oxidative abnormalities and cellular compensatory responses in Alzheimer disease (2006) (21)
- Glycogen Synthase Kinase 3: A Point of Integration in Alzheimer's Disease and a Therapeutic Target? (2012) (21)
- Early induction of c-Myc is associated with neuronal cell death (2011) (21)
- Alzheimer's disease: an intracellular movement disorder? (2005) (21)
- Iron: A Pathological Mediator of Alzheimer Disease? (2009) (20)
- Widespread distribution of reticulon‐3 in various neurodegenerative diseases (2010) (20)
- Mislocalization of CDK11/PITSLRE, a regulator of the G2/M phase of the cell cycle, in Alzheimer disease (2011) (19)
- A low-molecular-weight ferroxidase is increased in the CSF of sCJD cases: CSF ferroxidase and transferrin as diagnostic biomarkers for sCJD. (2013) (19)
- Down-regulation of aminolevulinate synthase, the rate-limiting enzyme for heme biosynthesis in Alzheimer's disease (2009) (18)
- Staying connected: synapses in Alzheimer disease. (2004) (18)
- Dynamin‐like protein 1 cleavage by calpain in Alzheimer’s disease (2019) (17)
- Prion Protein Protects against Renal Ischemia/Reperfusion Injury (2015) (17)
- Tau modifiers as therapeutic targets for Alzheimer's disease. (2005) (17)
- Amyloid-β Vaccination: Testing the Amyloid Hypothesis? : Heads We Win, Tails You Lose! (2006) (17)
- Alzheimer's Disease: Advances for a New Century (2012) (17)
- Neuropathology in Alzheimer's disease: awaking from a hundred-year-old dream. (2006) (16)
- Clinical and imaging characteristics of late onset mitochondrial membrane protein-associated neurodegeneration (MPAN) (2016) (16)
- Genome-wide analysis of DNA methylation during antagonism of DMOG to MnCl2-induced cytotoxicity in the mouse substantia nigra (2016) (15)
- Ascorbate distribution during hibernation is independent of ascorbate redox state. (2004) (15)
- Perspectives on the amyloid-beta cascade hypothesis. (2004) (15)
- Therapeutic potential of oxidant mechanisms in Alzheimer’s disease (2004) (15)
- Molecular neuropathogenesis of Alzheimer's disease: an interaction model stressing the central role of oxidative stress. (2012) (15)
- Mitochondrial Dynamics in Alzheimer's Disease Opportunities for Future Treatment Strategies (2010) (14)
- Treating the lesions, not the disease. (2007) (14)
- The essential role of ERK in 4‐oxo‐2‐nonenal‐mediated cytotoxicity in SH‐SY5Y human neuroblastoma cells (2009) (14)
- Increased Expression of p130 in Alzheimer Disease (2007) (14)
- The rs3756063 polymorphism is associated with SNCA methylation in the Chinese Han population (2016) (14)
- METTL3-dependent RNA m6A dysregulation contributes to neurodegeneration in Alzheimer’s disease through aberrant cell cycle events (2021) (13)
- Divalent metal transporter, iron, and Parkinson's disease: A pathological relationship (2010) (13)
- Chronic Leptin Supplementation Ameliorates Pathology and Improves Cognitive Performance in a Transgenic Mouse Model of Alzheimer's Disease. (2009) (13)
- Emerging evidence for the neuroprotective role of alpha-synuclein. (2006) (13)
- The role of Mfn2 in the structure and function of ER-mitochondrial tethering in vivo. (2021) (13)
- Inhibition of phosphodiesterase 2 reverses gp91phox oxidase-mediated depression- and anxiety-like behavior (2018) (13)
- The cell cycle and hormonal fluxes in Alzheimer disease: a novel therapeutic target. (2006) (13)
- The Role of Mitogen-Activated Protein Kinase Pathways in Alzheimers Disease (2002) (13)
- Ferric cycle activity and Alzheimer disease. (2005) (13)
- PPARγ Agonist Curcumin Reduces the Amyloid-β-Stimulated Inflammatory Responses in Primary Astrocytes (2010) (12)
- Mitochondrial Drugs for Alzheimer Disease (2009) (12)
- Oxidant and antioxidant responses in Alzheimer disease (2001) (11)
- Insights into the Impact of a Membrane-Anchoring Moiety on the Biological Activities of Bivalent Compounds As Potential Neuroprotectants for Alzheimer's Disease. (2018) (11)
- A second look into the oxidant mechanisms in Alzheimer's disease. (2005) (11)
- VPS35 D620N knockin mice recapitulate cardinal features of Parkinson’s disease (2021) (11)
- Heme Deficiency in Alzheimer's Disease: A Possible Connection to Porphyria (2006) (10)
- CD3 in Lewy pathology: does the abnormal recall of neurodevelopmental processes underlie Parkinson’s disease (2010) (10)
- Melatonin exhibits antioxidant properties in a mouse brain slice model of excitotoxicity. (2002) (10)
- Presenilin mutation: a deadly first hit in Alzheimer disease. A commentary on "aging sensitizes towards ROS formation and lipid peroxidation in PS1M146L transgenic mice". (2006) (9)
- Transcriptome-To-Metabolome™ Biosimulation Reveals Human Hippocampal Hypometabolism with Age and Alzheimer’s Disease (2011) (9)
- Insulin and Insulin-Sensitizing Drugs in Neurodegeneration: Mitochondria as Therapeutic Targets (2009) (9)
- Mfn2 Overexpression Attenuates MPTP Neurotoxicity In Vivo (2021) (9)
- Molecular Aspects of Neurodegeneration and Neuroprotection (2012) (9)
- Activation of P38 kinase links π phosphorylation, oxidative stress and cell cycle-related events in Alzheimer disease (2000) (8)
- Oxidative Stress Signaling in Blast TBI-Induced Tau Phosphorylation (2021) (8)
- Heme-a, the heme prosthetic group of cytochrome c oxidase, is increased in Alzheimer's disease (2009) (8)
- Cellular prion protein is essential for oligomeric amyloid- b -induced neuronal cell death (2012) (8)
- Altered redox balance in disease: Can we change the new equilibria? (2009) (7)
- Signal Transduction in Alzheimer’s Disease (2002) (7)
- The role of E2F1 in the development of hypertrophic cardiomyopathy. (2011) (7)
- Therapeutic potential of oxidative stress reduction in Alzheimer's disease (2006) (7)
- The sterol regulatory element‐binding protein 2 is dysregulated by tau alterations in Alzheimer disease (2019) (7)
- Redox active iron at the center of oxidative stress in Alzheimer disease (2005) (7)
- Apoptotic and Oxidative Indicators in Alzheimer’s Disease (2002) (6)
- Modulation of Parkinson's Disease Associated Protein Rescues Alzheimer's Disease Degeneration. (2016) (6)
- Human Tau Isoform Aggregation and Selective Detection of Misfolded Tau from Post-Mortem Alzheimer’s Disease Brains (2020) (6)
- HDL mimetic peptides affect apolipoprotein E metabolism: equal supplement or functional enhancer? (2018) (6)
- Neurogenesis in Human Hippocampus: Implications for Alzheimer Disease Pathogenesis (2006) (6)
- Amyotrophic lateral sclerosis: a novel hypothesis involving a gained 'loss of function' in the JNK/SAPK pathway (2003) (6)
- Ethnicity-specific and overlapping alterations of brain hydroxymethylome in Alzheimer's disease. (2019) (6)
- S4-02-01 Alzheimer disease: the two hit hypothesis (2004) (6)
- Alzheimer's Disease and Vascular Deficiency: Lessons from Imaging Studies and Down Syndrome (2012) (6)
- Heads We Win, Tails You Lose! (2006) (6)
- Neurofibrillary Tangle Formation as a Protective Response to Oxidative Stress in Alzheimer’s Disease (2009) (5)
- MDA and GSH levels in newly diagnosed Alzheimer's disease patients: A population-based study (2010) (5)
- Oncogenic parallels in Alzheimer disease (2006) (5)
- Selective Detection of Misfolded Tau From Postmortem Alzheimer’s Disease Brains (2022) (5)
- Vitamin C is a source of oxoaldehyde and glycative stress in age‐related cataract and neurodegenerative diseases (2020) (5)
- Memantine: "hypothesis testing" not "disease modifying" in Alzheimer's disease. (2010) (5)
- Amyloid-beta, BACE, and oxidative stress in Alzheimer's disease, a commentary on "The different aggregation state of beta-amyloid 1-42 mediates different effects on oxidative stress, neurodegeneration and BACE-1 expression". (2006) (5)
- Conditional Haploinsufficiency of β-Catenin Aggravates Neuronal Damage in a Paraquat-Based Mouse Model of Parkinson Disease (2018) (4)
- Therapeutic options in Alzheimers disease (2006) (4)
- Unexpected Implication of SRP and AGO2 in Parkinson’s Disease: Involvement in Alpha-Synuclein Biogenesis (2021) (4)
- Phosphodiesterase 2 inhibitor Hcyb1 reverses corticosterone-induced neurotoxicity and depression-like behavior (2020) (4)
- Alzheimer’s Disease: An Overview (2009) (4)
- In Vivo and In Silico Evidence: Hippocampal Cholesterol Metabolism Decreases with Aging and Increases with Alzheimers Disease -- Modeling Brain Aging and Disease (2011) (4)
- Untangling the Vascular Web from Alzheimer Disease and Oxidative Stress (2012) (4)
- Treatment advances in Alzheimer's disease based on the oxidative stress model (2009) (4)
- Correction: Individual Case Analysis of Postmortem Interval Time on Brain Tissue Preservation (2016) (4)
- Evidence for Oxidative Damage in the Autistic Brain (2009) (4)
- Absence of Cellular Stress in Brain Following Hypoxia Induced by Arousal from Hibernation in Arctic Ground Squirrels (2005) (4)
- Natural oxidant balance in Parkinson disease. (2009) (4)
- Amyloid-beta vaccination: testing the amyloid hypothesis?: heads we win, tails you lose! (2006) (4)
- Two Hits and You’re Out? A Novel Mechanistic Hypothesis of Alzheimer Disease (2008) (4)
- Isoform-specific roles of AMPK catalytic α subunits in Alzheimer's disease. (2020) (4)
- Oxidative Stress in Alzheimer’s Disease: A Critical Appraisal of the Causes and the Consequences (2011) (4)
- Transcriptome-To-Metabolome™ Biosimulation Reveals Human Hippocampal Hypometabolism with Age and Alzheimer's Disease (2011) (3)
- Oxidative Stress and Neurodegeneration: An Inevitable Consequence of Aging? Implications for Therapy (2010) (3)
- Hibernation, a Model of Neuroprotection (2001) (3)
- Alzheimer Disease: Oxidative Stress and Compensatory Responses (2009) (3)
- Amyloids, Aggregates and Neuronal Inclusions: Good or Bad News for Neurons? (2003) (3)
- Pathology's new role: defining disease process and protective responses. (2008) (3)
- Iron chelation and nanoparticle target delivery in the development of new multifunctional disease-modifying drugs for Alzheimer's disease. (2012) (3)
- The role of centromere cohesion and associated proteins in alzheimer's disease: A relation to aneuploidy? (2012) (3)
- Neurodegenerative Diseases: Mechanisms and Therapies (2006) (3)
- Mark Anthony Smith (1965-2010): Visionary, Alzheimer researcher, and editor-in-chief of the Journal of Alzheimer's Disease. (2011) (3)
- Oxidative Damage and Antioxidant Responses in Alzheimer's Disease (2002) (3)
- Oxidative Stress and Balance in Neurodegenerative Diseases (2011) (2)
- Mitochondria and Neurodegenerative Diseases (2010) (2)
- P3-219 Acetylation: a novel posttranslational modification in Alzheimer disease (2002) (2)
- Potential role of iron in a Mediterranean-style diet. (2010) (2)
- In Memoriam: Mark A. Smith, PhD (2011) (2)
- Role of Oxidative Insult and Neuronal Survival in Alzheimer’s and Parkinson’s Diseases (2008) (2)
- The origin of oxidative stress in neurodegenerative disease: Mark Anthony Smith 1965–2010 (2011) (2)
- P3-422: Impaired balance of mitochondrial fission and fusion in susceptible neurons of Alzheimer disease (2008) (2)
- Lipoic Acid and N‐Acetyl Cysteine Protect Against Mitochondrial‐Related Oxidative Stress in Fibroblasts from Alzheimer Disease Patients (2007) (2)
- Antioxidant Therapies in the Prevention and Treatment of Alzheimer Disease (2005) (2)
- Oxidative Stress in Parkinson’s Disease (2009) (2)
- A Pleotrophic Age for Alzheimer and Parkinson disease (2012) (2)
- Down syndrome and Alzheimer disease: A "multi-hit" hypothesis based on multiple contributing factors resulting in pleotrophic consequences (2011) (2)
- Mitochondrial dysfunction: mitochondrial diseases and pathways with a focus on neurodegeneration. Preface. (2010) (2)
- Ethanol-fixed, paraffin-embedded tissue imaging: implications for Alzheimer's disease research. (2020) (2)
- "Hypothesis Testing" not "Disease Modifying" in Alzheimer's Disease (2010) (2)
- Preface. Alzheimer's disease: advances for a new century. (2013) (2)
- Unveiling "the switch" from aging to Alzheimer's disease with the senescence-accelerated mouse model (SAMP8) (2011) (1)
- Antimicrobial peptide β-defensin-1 expression is upregulated in Alzheimer’s brain (2013) (1)
- Posttranslational modifications of α-tubulin in alzheimer disease (2015) (1)
- Abnormal mitochondrial dynamics in Alzheimer disease (2008) (1)
- P1-266 The critical role of the ERK pathway in the pathogenesis of Alzheimer's disease (2004) (1)
- Altered Hydroxymethylome in the substantia Nigra of Parkinson's disease. (2022) (1)
- Signal Transduction in Alzheimers Disease (2002) (1)
- The Fallacy of Amyloid and Cognition in Alzheimer’s Disease (2006) (1)
- Oxidative Stress and Neuronal Adaptation in Alzheimer Disease (2003) (1)
- The Roc Domain of Leucine-Rich Repeat Kinase 2 ( LRRK 2 ) is Sufficient for Interaction with Microtubules (2008) (1)
- Neuronal Survival and Death in Alzheimer Disease (2002) (1)
- Sequestration of p27 within the cytoplasm of cardiac myocytes in chronic ischemic heart disease: pathogenic implications for ischemic cardiomyopathy (2006) (1)
- Neurodegenerative processes in Alzheimer's disease: an overview of pathogenesis with strategic biomarker potential (2011) (1)
- Mark A. Smith: the scientist, the man. (2011) (1)
- Oxidative Stress and Alzheimer Disease: Mechanisms and Therapeutic Opportunities (2011) (1)
- P3-317: Failure in the control of cell cycle causes neurodegeneration (2008) (1)
- Amyloid-Vaccination : Testing the Amyloid Hypothesis ? (2006) (1)
- Mfn2 ablation causes an oxidative stress response and eventual neuronal death in the hippocampus and cortex (2018) (1)
- Oxidative damage is correlated with mitochondrial autophagy (2015) (0)
- ABNORMAL MITOCHONDRIAL DYNAMICS AS A THERAPEUTIC TARGET FOR ALZHEIMER DISEASE (2016) (0)
- Oxidative stress and neuropsychiatric disorders in the life spectrum (2017) (0)
- Dystrophic neurites labelled by pre-autophagosomal proteins in Alzheimer’s brains (2019) (0)
- Consent: Practical Principles for Clinicians (2011) (0)
- Endoplasmic reticulum-mitochondria tethering in neurodegenerative diseases (2017) (0)
- P3-229 P130, a regulator of the G1 phase of the cell cycle, in Alzheimer disease: Evidence of a stuttered cell cycle (2006) (0)
- Mitochondrial abnormalities and oxidative stress in Alzheimer's disease (2011) (0)
- Abnormal CDK11/PITSLRE cell cycle dynamics mediated by app: relevance to Alzheimer's disease (2011) (0)
- Mark A. Smith, 1965-2010: consummate student of pathogenesis. (2011) (0)
- Latrepirdine (Dimebon™) modulate mitochondrial dynamics in AD cell models (2010) (0)
- Increased Phosphorylation and Mitochondrial Association of Bax in the Brains of Alzheimer's Disease Individuals (2017) (0)
- In Memoriam: Mark A. Smith, PhD: Neuroscientist and Visionary (2011) (0)
- Alzheimer's disease: Pathology vs etiology (2007) (0)
- Protein Misfolding in Alzheimer's Disease: Pathogenic or Protective? (2007) (0)
- Mini-Forum “Mitochondria in Alzheimer Disease” (2007) (0)
- R-α-lipoic acid as a potent agent of mitochondrial protection in alzheimer’s disease (2012) (0)
- Disturbance in AMP-activated protein kinase (AMPK) signaling pathway in Alzheimer's disease (2010) (0)
- The Importance of Histochemical Detection of Oxidative Damage in Tissue (2010) (0)
- Pathological phenotype in familial neurodegenerative disease: implications for families and therapeutic constructs (2011) (0)
- CXCL12 is involved in α-synuclein-triggered neuroinflammation of Parkinson’s disease (2019) (0)
- Correction: Prion Protein Protects against Renal Ischemia/Reperfusion Injury (2015) (0)
- Neuronal leptin resistance in Alzheimer's disease (2013) (0)
- DLP1‐Dependent Mitochondrial Fragmentation Mediates 1‐methyl‐4‐phenylpyridinium (MPP+) Toxicity in Neurons (2011) (0)
- Oxidative Damage to RNA in Aging and Neurodegenerative Disorders (2012) (0)
- Cell cycle aberrations mediate neurotoxicity induced by soluble amyloid-beta oligomers (2011) (0)
- P4-170: Peroxidative nitrotyrosine formation in Alzheimer's disease (2008) (0)
- Abnormal activation of protein kinase C theta in Alzheimer's disease: Pathological implications (2010) (0)
- Neuronal failure in Alzheimer’s disease: a view through the oxidative stress looking-glass (2014) (0)
- P1-388 Failure of cytoplasmic-nuclear transport in Alzheimer’s disease (2006) (0)
- The Potential Application of Antioxidant Agents in Alzheimer Disease Therapeutics (2007) (0)
- Alzheimer's Disease: Foreword (2004) (0)
- Neuroprotective effects of hypoxic preconditioning on streptozotocin-induced animal model of sporadic Alzheimer's disease (2011) (0)
- Dissociated Aβ antibody level in newly diagnosed Alzheimer's disease: A population-based study (2009) (0)
- Oxidative Damage is Correlated with Mitochondrial Autophagy (2015) (0)
- P3-375 Lipoic acid and N-acetyl cysteine protect against mitochondrial-related oxidative stress in fibroblasts from Alzheimer disease patients (2006) (0)
- P2-011 A BIOENERGETIC TRAJECTORY OF FEMALE BRAIN AGING AND ALZHEIMER’S DISEASE 1: IMPLICATIONS FOR RISK PREVENTION AND TREATMENT (2013) (0)
- PREFRONTAL CORTEX TRANSCRIPTOME BY MULTIPLE RNA-SEQUENCING (2013) (0)
- Oxidative Stress Associated Signal Transduction Cascades in Alzheimer Disease (2009) (0)
- Restoring brain NAD+ and blood-brain barrier integrity to optimize brain health and identify neuroprotective targets (2022) (0)
- Contents Vol. 4, 2006–2007 (2008) (0)
- Presenilin mutations impair mitochondrial dynamics in neurons (2013) (0)
- Streamlined alpha-synuclein RT-QuIC assay for various biospecimens in Parkinson’s disease and dementia with Lewy bodies (2021) (0)
- Upcoming Meetings Related to Alzheimer's Disease. (2007) (0)
- PPAR γAgonis tCurcumi nReduce sthe Amyloid-β-Stimulate dInflammatory Responses in Primary Astrocytes (2010) (0)
- P3-306 Differential expression of metabotrophic glutamate receptors (MGlurs) in Alzheimer disease (2004) (0)
- P4-162: LRRK2 in Lewy bodies of Parkinson’s disease and dementia with Lewy bodies (2006) (0)
- Mark Smith: Pioneer of Alzheimer Disease Research (2012) (0)
- Mark Smith: Pioneer of Alzheimer Disease Research (2012) (0)
- Review for "Overexpression of α‐synuclein inhibits mitochondrial Ca 2+ trafficking between the endoplasmic reticulum and mitochondria through MAMs by altering the GRP75–IP3R interaction" (2021) (0)
- Cell cycle dysregulation and neurodegenerative diseases (2007) (0)
- P4-166: Overexpression of amyloid precursor protein causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins (2008) (0)
- Ablation of Mitochondria Fusion Protein Mfn2 causes an Oxidative Stress Response and Eventual Neuronal Death in the Hippocampus and Cortex (2017) (0)
- Decline in mitochondrial bioenergetics underlies central insulin resistance in streptozocin-induced model of sporadic Alzheimer's disease (2011) (0)
- Antibody‐Antigen Dissociation: A Novel Diagnostic Tool in Alzheimer Disease (2008) (0)
- Mark A. Smith: Scholar and Innovator (2011) (0)
- Oxidative Adaptation in Aging and Alzheimer’s Disease: The Roles of Amyloid and Tau (2005) (0)
- Association of mitochondrial signaling in Alzheimer's disease and hypoxia (2011) (0)
- Mitochondrial Fragmentation Mediates MPP+ Toxicity in Neurons: Implications for Parkinson's Disease (2011) (0)
- Mitochondrial dynamic abnormalities in amyotrophic lateral sclerosis (2015) (0)
- P1-351: A novel approach to diagnosis: Antigen-antibody disassociation in Alzheimer's disease (2008) (0)
- ApoE and mitochondrial dysfunction (2020) (0)
- Neurogenesis in Alzheimer’s Disease (2006) (0)
- Damaged mitochondria coincide with presynaptic vesicle loss and abnormalities in alzheimer’s disease brain (2023) (0)
- P1-417 Ectopic localization of phospho-Smad2 in the vulnerable neurons of Alzheimer’s disease (2006) (0)
- Conditional Haploinsufficiency of β-Catenin Aggravates Neuronal Damage in a Paraquat-Based Mouse Model of Parkinson Disease (2018) (0)
- Mitochondria Dynamics Abnormalities in Alzheimer Disease (2009) (0)
- Mark A. Smith, PhD: Renegade Scientist and Visionary (2011) (0)
- The concept of redox balance in Alzheimer's disease: Mark Anthony Smith 1965–2010 (2011) (0)
- Mark A. Smith: neurocytochemistry innovator. (2012) (0)
- Therapeutic opportunities in Alzheimer disease: Current concepts (2009) (0)
- Upcoming Meetings Related to Alzheimer's Disease. (2016) (0)
- NLRP3 Inflammasome Inhibitor Ameliorates Amyloid Pathology in a Mouse Model of Alzheimer’s Disease (2017) (0)
- Astrin, a substrate of GSK3β is differentially expressed in AD compared to age-matched controls (2009) (0)
- P1-369 Evidence of gonadotropin-induced steroidogenesis in Alzheimer’s disease (2006) (0)
- O2-04-07 Elevated expression of a regulator of the G2/M phase of the cell cycle, neuronal CIP-1 associated regulator of cyclin B, in Alzheimer disease (2004) (0)
- Using biology to untie the Gordian knot of Alzheimer's disease (2011) (0)
- O4-02-08 Mitochondrial autophagocytosis in Alzheimer disease (2006) (0)
- Protective effects of phosphodiesterase 2 inhibitor against Aβ1-42 induced neuronal toxicity (2022) (0)
- Mitochondria dysfunction in the pathogenesis of Alzheimer’s disease: recent advances (2020) (0)
- Thinking Outside the Box in Alzheimer Disease Treatment (2011) (0)
- Birth of JAD: 20 Years Later (2018) (0)
- Commentary Do Neurons Have a Choice in Death (2001) (0)
- Chapter 19:Targeting Oxidative Mechanisms in Alzheimer Disease (2010) (0)
- Alzheimer’s disease (AD), the most common neurodegener- ative disorder of the elderly, is characterized by senile plaques, neurofibrillary tangles, and progressive death of neuronal cells at selective brain regions (Smith 1998). The molecular mechanisms underlying the pathogenesis of AD (2012) (0)
- Alzheimer's disease therapy: a moving target (2011) (0)
- Metal Homeostasis and Its Relation to Oxidative Stress in Alzheimer’s Disease (2003) (0)
- Mitochondrial abnormalities at the origin of oxidative stress in Alzheimer?s disease (2013) (0)
- Analysis of intracellular amyloid‐β as a consistent feature of hippocampal neurons (2011) (0)
- Mark A. Smith: Impresario of Alzheimer (2011) (0)
- Amyloid- _ and _ in Alzheimer’s Disease: What is the Neuropathology Trying to Tell Us? (2005) (0)
- Space-like radiation causes accelerated cognitive impairment and increased Alzheimer's-like pathology in CRND8 APP transgenic mice (2013) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Xiong-wei Zhu?
Xiong-wei Zhu is affiliated with the following schools:
